Fact sheet: Janus Henderson GlLfSc

Fund information

Fund name
Janus Henderson Global Life Sciences A Acc USD
Fund company manager
Janus Capital Funds
Fund type
SIB
Fund manager(s)
Andrew R Acker
since 01/05/2007
Ethan Lovell
since 12/01/2016
Fund objective
This global health care fund seeks consistent returns by investing in companies addressing unmet medical needs or making the health care system more efficient. We balance the portfolio across pharmaceuticals, biotechnology and services/devices sub-sectors in an effort to achieve similar or lower volatility relative to our peers.
Benchmark
MSCI World Healthcare
Investment style
None
Investment method
Shares

Performance snapshot

Sector
Fund
Sector
Fund
Sector
Fund

Quick stats

1 Year return

21.54 %

1 Year rank in sector

7/30

Sector

FO Equity - Pharma Health & Biotech

Yield
-
Fund size

£ 2.0 b

FE Risk score

161

NAV
-
Discount/Premium
-
Gearing
-

Top in sector

Holdings snapshot

  • USA
    76.16%
  • UK
    7.66%
  • France
    4%
  • Switzerland
    3.93%
  • Japan
    2%
  • Biotechnology/Medical
    36.59%
  • Pharmaceuticals
    29.54%
  • Healthcare & Medical Products
    15.7%
  • Health Care
    14.25%
  • Hospital
    2.07%
  • US Equities
    75.68%
  • International Equities
    21.98%
  • Cash & Cash Equivalents
    1.85%
  • Convertibles
    0.4%
  • Other International Equities
    0.09%

Performance vs. Sector

Sector
Fund
Sector
Fund
Sector
Fund

Cumulative performance

1m6m1y3y5y
Fund5.37 %5.13 %21.54 %11.08 %118.15 %
Sector3.43 %3.22 %14.65 %12.18 %95.8 %
Rank within sector5 / 3113 / 317 / 3012 / 276 / 23
Quartile th1 st2 nd1 st2 nd2 nd

Calendar performance

YTD-20182017201620152014
Fund4.85 %20.55 %-13.79 %5.69 %32.75 %
Sector3.02 %14.94 %-9.92 %7.24 %28.08 %
Rank within sector3 / 319 / 3019 / 3018 / 2714 / 24
Quartile th1 st2 nd3 rd3 rd3 rd

Risk statistics

Alpha-0.3
Beta1.03
Sharpe-0
Volatility16.33
Tracking error4.92
Information ratio-0.07
R-Squared0.91

Price movement

52 week high31.5
52 week low25.21
Current bid price0
Current offer price0
Current mid price31.41

Holdings by region

  • 76.16% USA
  • 7.66% UK
  • 4% France
  • 3.93% Switzerland
  • 2% Japan
  • 1.85% Money Market
  • 1.72% Germany
  • 1.41% Denmark
  • 0.96% Belgium
  • 0.31% Hungary

Holdings by sector

  • 36.59% Biotechnology/Medical
  • 29.54% Pharmaceuticals
  • 15.7% Healthcare & Medical Products
  • 14.25% Health Care
  • 2.07% Hospital
  • 1.85% Cash & Cash Equivalents

Holdings by asset type

  • 75.68% US Equities
  • 21.98% International Equities
  • 1.85% Cash & Cash Equivalents
  • 0.4% Convertibles
  • 0.09% Other International Equities

Individual holdings

  • 3.3% AETNA INC NEW
  • 3% ASTRAZENECA PLC
  • 3% LILLY (ELI) & CO
  • 3% SANOFI
  • 2.8% SHIRE PLC
  • 2.4% CELGENE CORP
  • 2.4% HUMANA INC
  • 2.3% ANTHEM INC
  • 2.2% BIOGEN INC
  • 2.2% NOVARTIS AG